November 12, 2026
CellCarta is a global CRO that brings genomics, histopathology, immunology, and proteomics together, giving you the scientific depth, operational scale, and hands-on partnership your program deserves from discovery through phase III trials and CDx.
In this one-pager, learn more about the therapeutic areas and modalities we can support for precision medicine programs of any scale and complexity. By applying a flexible, multi-omics approach, our global team of scientists deliver reliable, regulatory-ready data and insights to drive your program forward.
